1,25-Dihydroxyvitamin D

Developed for: NAFLD1
Investigated by: Pliva Hrvatska d.o.o. · University Hospital Rijeka · University of Rijeka

today NCT04038853 · Ph 4

201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT04038853	Dec 2015 → Feb 2017	NAFLD1, vitamin D deficiency	University Hospital Rijeka	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	1,25-Dihydroxyvitamin D	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04038853 ↗
Route	Oral	“1,25-dihydroxy-vitamin D3 1000 IU orally daily for 12 months” NCT04038853 ↗